Lantus and Ocrelizumab Intravenous
Determining the interaction of Lantus and Ocrelizumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Lantus, Lantus Solostar Pen, Basaglar KwikPen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: n.a.
Generic Name: ocrelizumab
Brand name: Ocrevus
Synonyms: Ocrelizumab (Intravenous), Ocrelizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lantus-Ocrevus
- Lantus-Octagam
- Lantus-Octagam Gammagard S/D
- Lantus-Octocaine
- Lantus-Octocaine 100
- Lantus-OctreoScan
- Ocrelizumab Intravenous-Lantus SoloStar
- Ocrelizumab Intravenous-Lantus SoloStar (Insulin Glargine (U-100) Cartridge Systems and Pens)
- Ocrelizumab Intravenous-Lantus Solostar (Insulin Glargine (U-300) Pens)
- Ocrelizumab Intravenous-Lantus Solostar Pen
- Ocrelizumab Intravenous-Lapatinib
- Ocrelizumab Intravenous-Lapatinib Ditosylate